ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,224, issued on Sept. 29, was assigned to ETH ZURICH (Zurich).
"Compounds for treating CNS- and neurodegenerative diseases" was invented by Ursula Quitterer (Zurich) and Said Abdalla (Mainz, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to compounds and corresponding pharmaceutical formulations for use in the medical treatment of CNS- and neurodegenerative diseases, for example, for use in the treatment and prophylaxis of familial or sporadic Alzheimer's disease. The invention further relates to corresponding methods of treatment and to a method for determining treatment progression or outcome of senescence...